Jason V. Coloma, CEO: Maze Therapeutics MAZE Sell · Filed 06/24

Trade details

Type: Insider sale
Amount: $53,040
Shares · price: 2,040 sh · $26.00 a share
Held after: 25,930 sh
Stock: Maze Therapeutics MAZE
Person: Jason V. ColomaCEO
Trade date: 26/06/22
Filed: 26/06/24
Days to filing: 2 days

Sold 7.3% of holdings

Share of holding sold: 7.3%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 05/23~07/22

Jason V. Coloma's recent trades

Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$933.3K
34,501 sh
$933.3K
Filed 10/01
Traded 10/01
Jason V. ColomaCEO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$623.4K
23,497 sh
$623.4K
Filed 09/02
Traded 09/02
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$908.1K
34,501 sh
$908.1K
Filed 09/01
Traded 09/01
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$922.6K
34,501 sh
$922.6K
Filed 08/03
Traded 08/03
Jason V. ColomaCEO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1M
34,501 sh
$1M
Filed 07/01
Traded 07/01

Jason V. Coloma, CEO — sold $53K of Maze Therapeutics MAZE · 7.3% of holdings · 10b5-1 plan | Whalegun